The UK government has selected Pfizer to supply millions of respiratory syncytial virus (RSV) vaccine doses, snubbing local pharma company GSK and its competing product …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.